Cancer Seminar Series
Join us for this interdisciplinary seminar series highlighting cutting edge clinical, translational, and basic research topics in cancer from our research partner institutes: UQ Diamantina, QUT and the Mater. Focussing primarily on communicating the findings of early-to-mid career researchers, new faculty members along with notable guest speakers, this seminar series serves as an important tool to promote discussion and collaboration.
Key Researchers
- Dr Katharina Noske
- Dr Jenni Gunter
- Dr Mark Adams
- Dr Yaowu He
Key Aims
- Promote researchers
- Encourage discussion
- Enable collaboration
- Share techniques
2018 Schedule
| Date | Speakers | Title |
| 22/02/2018 | Dr. Jatin Patel (UQDI) | Endovascular progenitors initiate and drive de novo vascularisation in melanoma |
| Dr. Nathalie Bock (QUT) | An in vitro bioengineered bone model to study the effects of androgen deprivation in the bone metastatic microenvironment of prostate cancer | |
| 08/03/2018 | TBC | TBC |
| Abdullah Al Emran (Dermatology Research Centre, UQDI) | Commonly integrated epigenetic modifications of differentially expressed genes lead to acquired drug resistance in cancer | |
| 22/08/2018 | Cancelled | |
| 05/04/2018 | Prof. Amanda Spurdle (QIMR) | Clinical classification of genetic variants: Research informing practice |
| 19/04/2018 | Prof. Nikolas Haass (UQDI) | RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes |
| Farhana Matin (QUT) | A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer | |
| 03/05/2018 | Dr. Chris Slape (UQDI) | EphA3: A new kind of oncogene |
| Dr. Mitchell Stark (Dermatology Research Centre, UQDI) | Whole exome analysis of naevi reveals mechanisms for development and maintenance of benign neoplasms | |
| 17/05/2018 | Dr. Rehan Villani (UQDI) | Deciphering the role of cancer-associated fibroblasts in basal cell carcinoma |
| Arutha Kulasinghe (QUT) | Circulating tumour cells: the "leukemic" phase of solid cancers | |
| 31/05/2018 | ||
| Dr. Dubravka Skalamera (MRI) | Using high-content time-lapse imaging to investigate effects of oncogenic mutations in melanocyte-keratinocyte-fibroblast interaction | |
| 14/06/2018 | Dr. Abu Sina (AIBN, UQ) | Interfacial Biosensing: A new avenue for sensing cancer biomarkers |
| 28/06/2018 | Dr. Lutz Krause (UQDI) | TBC |
| 12/07/2018 | ||
| 26/07/2018 | Cancelled due to TRI symposium | |
| 09/08/2018 | Prof. Glen Boyle (QIMR) (TRI auditorium) | TBC |
| 23/08/2018 | Dr. Samantha Stehbens (UQDI) | TBC |
| 06/09/2018 | Dr. Julia Pagan (UQ School of Biomed. Sc.) | TBC |
| 20/09/2018 | ||
| Prof. Riccardo Dolcetti | TBC | |
| 04/10/2018 | Dr. Daniel Kerage (UQDI) | TBC |
| 18/10/2018 | Dr. Shannon Joseph (UQDI) | TBC |
| Heinz Hammerlindl (Dermatology Research Centre, UQDI) | TBC | |
| 01/11/2018 | ||
| 15/11/2018 | ||
| 29/11/2018 | Joachim Torrano (Dermatology Research Centre, UQDI) | TBC |
2017 Schedule Archive
| Date | Speakers | Topic |
| 09/03/2017 | Dr. Yaowu He (Mater) | Functional importance of CDCP1 in colorectal cancer |
| Dr. Jatin Patel (UQDI) | Defining the vascular stem cell niche for cancer and tissue regeneration | |
| 23/03/2017 | Dr. Orla Gannon (UQDI) | Are pathogens associated with breast cancer? |
| Phoebe Sarkar (APCRC-Q) | Characterizing the role of insulin in advanced prostate cancer | |
| 06/04/2017 | Dr. Pascal Duijf (UQDI) | Pan-cancer analysis identifies novel features of chromosome arm-level somatic copy number aberrations |
| Chris Oh (IMB, UQ) | Epigenetic signalling of nuclear hormone receptor and cofactor in breast cancer | |
| 20/04/2017 | TBC | TBC |
| 04/05/2017 | Prof. Riccardo Dolcetti (UQDI) | Personalized immunotherapy to overcome tumour heterogeneity |
| 18/05/2107 | Abdullah Emran (UQDI / Dermatology Research Centre) | Distinct histone modifications define early drug resistance in cancer |
| Jana Panchadsaram (APCRC-Q) | The role of 5p15 locus in prostate cancer risk and progression | |
| 01/06/2017 | Dr. Kyle Upton (UQ School of Chemistry) | Mobile genetic elements in epithelial cancers |
| 15/06/2017 | Dr. Samantha Stehbens (UQDI) | Fibroblast Growth Factor Receptor 2 activating mutations Potentiate Migration and Invasion in Endometrial Cancer |
| Heinz Hammerlindl (UQDI / Dermatology Research Centre) | H3K4me3 remodelling drives acquired BRAF inhibitor resistance in melanoma | |
| 29/06/2017 | Kaylyn Tousignant (QUT) | Enhanced lipid uptake: a novel target to fight the adaptive response to androgen-targeted therapies in prostate cancer |
| Thomas Keech (Mater) | Bone marrow macrophages in acute myeloid leukaemia | |
| 13/07/2017 | Sharon Del Vecchio (UQDI, PAH) and Dr. Aaron Urquhart (Diagnostic Imaging, TRI) | Decoding the spectral fingerprint of kidney cancer |
| 27/07/2017 | Dr Honor Hugo (QUT) | Insight into mammographic density from human breast tissue cultivated ex vivo |
| Dr Ati Taherian Fard (APCRC-Q) | Temporal transcriptional dynamics of ZEB1-induced EMT in prostate cancer | |
| 10/08/2017 | Dr. Andreas Moeller (Head of Tumour Microenvironment, QIMR Berghofer) | Cancer-derived exosomes as new prognostic markers |
| 24/08/2017 | Dr. Stephen Mattarollo (UQDI) | Neuro-immuno-metabolic interactions in the tumour microenvironment |
| Scott Lovell (Visiting scholar, QUT) | Novel activity-based probes for the assessment of KLK activities in prostate cancer | |
| 07/09/2017 | Prof. Stacey Edwards (QIMR) | From GWAS to new drug targets for breast cancer |
| 21/09/2017 | Dr. Patricia Carreira Moreno (Mater) | Selection of a tumour-specific L1 insertion in the STC1 gene after chemotrherapy in an ovarian cancer patient |
| Farzana Ahmed (UQDI) | The role of MITF in melanoma tumour heterogeneity and drug resistance | |
| 05/10/2017 | Dr. James Wells (UQDI) | Rapamycin-induced reduction of de novo squamous cell carcinoma establishment - a role for CD8-T-cells? |
| 19/10/2017 | Dr. Shannon Joseph (UQDI) | Reversing resistance to monoclonal antibody therapy in metastatic Head and Neck Squamous Cell Carcinoma and triple negative breast cancers - CESTEM trial update |
| 02/11/2017 | Prof. Shubha Chiplunkar (Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India) | Gamma delta T cells and cancer immunotherapy |
| Rayzel Fernandes (Dame Roma Mitchell Cancer Research Labs, University of Adelaide) | miR-194 regulates androgen receptor signalling in prostate cancer | |
| 16/11/2017 | Dr. Abbas Shafiee (ihbi) | TBC |
| 22/11/2017 | Special Cancer-Immunology seminar: International speaker Professor Tetsuo Akimoto (National Cancer Center Hospital East, Japan) | Proton beam therapy: state-of-the-art technology to target cancer. Clinical outcomes and current status in Japan |
| 30/11/2017 | Dr. Loredana Spoerri (UQDI) | MITF regulates dynamic heterogeneity and structural integrity in melanoma |
2016 Schedule archive
| Date | Speakers | Topic |
| 14/04/2016 | Dr Peter Simpson | Invasive lobular carcinoma – a special type of breast cancer |
| 28/04/2016 | Dr Graham Leggat | Tissue-resident memory T cells in precancerous skin |
| Shiv Hiriyur Nagaraj | TBC | |
| 12/05/2016 | Dr Stephen Matarollo | Improving response to immunotherapy in blood cancers |
| Dr Daniela Loessner | Engineering of tumour microenvironments | |
| 26/05/2016 | Dr Mitch Starck | "Melanoma-microRNAs”: from novel disease biomarkers through to target gene identification and regulation. |
| 9/06/2016 | Dr James Wells | Understanding the involvement of CD8 T-cells in the control of cutaneous squamous cell carcinoma |
| Dr Yonghua Sheng | MUC13 Protects Colorectal Cancer Cells from Death by Activating the NF-κB Pathway and Is a Potential Therapeutic Target | |
| 23/06/2016 | Dr Aaron Smith | External Speaker (SBMS) Melanoma |
| 7/07/2016 | QUT Speaker | TBC |
| Mater Speaker | TBC | |
| 21/07/2016 | Dr Jatin Patel | Defining the vascular stem cell niche for cancer and tissue regeneration |
| 4/08/2016 | Dr Lynn Fink | Using the MLL Fusion Transcriptome for Diagnosis in Childhood Acute Myeloid Leukaemia |
| Dr Eloise Dray | Exploiting DNA repair defects in breast cancer | |
| 18/08/2016 | John Price | External Speaker: Victoria Uni |
| 1/09/2016 | Dr Alice Kamphorst | RESCUE OF EXHAUSTED CD8 T CELLS BY PD-1 TARGETED THERAPIES IS CD28-DEPENDENT |
| Mater | TBC | |
| 29/09/2016 | Dr Alok Shah | TBC |
| Thomas Kryza | TBC | |
| 13/10/2016 | Srividya Vaidyanathan | TBC |
| Vanessa Bonazzi | TBC | |
| 27/10/2016 | Dr Graeme Walker | External Speaker (QIMR) : Melanoma |
| 10/11/2016 | TBC | Mater |
| TBC | QUT | |
| 24/11/2016 | TBC | External Speaker |
| 8/12/2016 | Dr Loredana Spoerri | Melanoma |
| QUT | TBC |
